Researcher
Bénédicte Dubois
- Disciplines:Neurosciences
Affiliations
- Research Group Experimental Neurology (Division)
Responsible
From1 Feb 2014 → Today - Laboratory for Neuroimmunology (Lab)
Responsible
From1 Jan 2006 → Today - Laboratory for Neuroimmunology (Lab)
Member
From1 Jan 2012 → 31 Mar 2016 - Research Group Experimental Neurology (Division)
Member
From1 Oct 2003 → Today - Department of Neurosciences (Department)
Member
From1 Oct 2001 → 30 Sep 2003 - Immunobiology (Rega Institute) (Lab)
Member
From1 Oct 1999 → 30 Sep 2001
Projects
1 - 10 of 19
- Multiple sclerosis immunogenetics: moving to multimodal single-cell resolutionFrom1 Jan 2024 → TodayFunding: FWO research project (including WEAVE projects)
- The role of natural killer cell subsets in the multiple sclerosis brainFrom1 Dec 2023 → TodayFunding: Private funding of national origin - undefined
- Multiple sclerosis immunogenetics.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Identifying novel insights into molecular pathways that contribute to axonal loss in progressive multiple sclerosis.From1 Oct 2022 → TodayFunding: BOF - ZAP BOF mandates
- Elucidating the role of Epstein-Barr virus in multiple sclerosis pathophysiology.From1 Oct 2022 → TodayFunding: FWO fellowships
- The Role of Natural Killer Cells in Multiple SclerosisFrom1 Sep 2021 → TodayFunding: FWO fellowships
- Multiple sclerosis immunogenetics: moving to multi-omics single-cell resolutionFrom1 Sep 2021 → TodayFunding: FWO fellowships, Foreign private sponsor - undefined
- Inter-individual variation in susceptibility to and disease course of multiple sclerosisFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Somatic mutations leading to CD8+ T cell proliferation contribute to the pathogenesis of multiple sclerosisFrom1 Jan 2019 → 31 Dec 2022Funding: FWO research project (including WEAVE projects)
- Multiple sclerosis postdoctoral research fellowship Emanuela Oldoni.From5 Feb 2018 → 4 Feb 2020Funding: Foreign Nonprofit organisations and equivalents
Publications
41 - 50 of 99
- Corticosteroids in the management of acute multiple sclerosis exacerbations(2017)
Authors: Ide Smets, Lieselot Van Deun, Ludo Vanopdenbosch, Bénédicte Dubois
Pages: 623 - 633 - New insights into the burden and costs of multiple sclerosis in Europe: Results for Belgium(2017)
Authors: Bénédicte Dubois, Gisela Kobelt, Jenny Berg, Daniela Capsa, Mia Gannedahl
Pages: 29 - 40 - New insights into the burden and costs of multiple sclerosis in Europe: Results for Belgium(2017)
Authors: Bénédicte Dubois
Pages: 29 - 40 - Power estimation for non-standardized multisite studies(2016)
Authors: Philippe Demaerel, Bénédicte Dubois, An Goris
Pages: 281 - 294 - Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations(2016)
Authors: James Dooley, Ine Pauwels, Dean Franckaert, Ide Smets, Josselyn Eloyna Garcia Perez, Kelly Hilven, Dina Danso-Abeam, Joanne Terbeek, Thi Loan Anh Nguyen, Louis De Muynck, et al.
- Immunologic profiles of multiple sclerosis treatments reveal shared early B cell alterations(2016)
Authors: James Dooley, Ine Pauwels, Dean Franckaert, Ide Smets, Josselyn Eloyna Garcia Perez, Kelly Hilven, Dina Danso-Abeam, Joanne Terbeek, Thi Loan Anh Nguyen, Louis De Muynck, et al.
- Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients(2016)
Authors: Kelly Hilven, Bénédicte Dubois, An Goris
Pages: 2073 - 2079 - NR1H3 p.Arg415Gln Is Not Associated to Multiple Sclerosis Risk(2016)
Authors: Bénédicte Dubois, An Goris
Pages: 333 - 335 - CCR2 defines in vivo development and homing of IL-23-driven GM-CSF-producing Th17 cells.(2015)
Authors: Ervin E Kara, Duncan R McKenzie, Cameron R Bastow, Carly E Gregor, Kevin A Fenix, Abiodun D Ogunniyi, James C Paton, Matthias Mack, Diana R Pombal, Cyrill Seillet, et al.
Pages: 8644 - Characteristic callosal involvement in Susac's syndrome(2015)
Authors: Alexandra Seghers, Guy Wilms, Bénédicte Dubois
Pages: 395 - 396